| L-glutamine Treatment in Patients With Diverticulosis (NCT05106101) | Emmaus Medical, Inc. | 2019-07-19 |
| A Study to Determine the Metabolism and Elimination of [14C]E2027 in Healthy Male Participants (NCT04023877) | Eisai Inc. | 2019-07-18 |
| A Single and Multiple Ascending Dose Study of BMS-986318 in Healthy Participants (NCT04082741) | Bristol-Myers Squibb | 2019-07-18 |
| Autologous Natural Killer Cells in Subjects With Plaque Psoriasis (NCT03894579) | NKGen Biotech, Inc. | 2019-07-18 |
| DOSE Trial of Opioid Sparing Effect (NCT03938857) | Duke University | 2019-07-18 |
| QUILT-3.064: PD-L1 t-haNK In Subjects With Locally Advanced Or Metastatic Solid Cancers (NCT04050709) | ImmunityBio, Inc. | 2019-07-18 |
| Safety and Therapeutic Drug Monitoring of Cefazolin in Continuous Renal Replacement Therapy (NCT03672149) | Drexel University | 2019-07-18 |
| A Study of a Personalized Cancer Vaccine Targeting Shared Neoantigens (NCT03953235) | Gritstone bio, Inc. | 2019-07-18 |
| CPX-351 and Gemtuzumab Ozogamicin in Treating Patients With Relapsed Acute Myeloid Leukemia (NCT03904251) | Jonsson Comprehensive Cancer Center | 2019-07-18 |
| An Exploratory Clinical Trial Evaluating the Tolerability and Efficacy of KH906 in Patients With Corneal Neovascularization (NCT04215393) | Chengdu Kanghong Biotech Co., Ltd. | 2019-07-18 |
| A Study to Evaluate the Safety and Efficacy of DDO-3055 in Healthy Volunteers and Patients With Chronic Kidney Disease (NCT03976115) | Jiangsu HengRui Medicine Co., Ltd. | 2019-07-18 |
| First in Human Clinical Trial of ApTOLL in Healthy Volunteers (NCT04742062) | aptaTargets S.L. | 2019-07-18 |
| A Phase I Study of BPI-16350 in Patients with Advanced Solid Tumor (NCT03791112) | Betta Pharmaceuticals Co., Ltd. | 2019-07-18 |
| Study of Commercial and Phase 3 of PF-04965842 Formulations, Estimation of Effect of Food on Commercial Formulation (NCT04065633) | Pfizer | 2019-07-18 |
| Capecitabine and Radiotherapy in the Adjuvant Treatment of Resistant Breast Cancer (NCT03958721) | A Bapsi Chakravarthy, MD | 2019-07-18 |
| Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Combinations of Monoclonal Antibodies PGT121, PGDM1400, 10-1074, and VRC07-523LS Administered Via Intravenous Infusion in Healthy, HIV-uninfected Adult Participants (NCT03928821) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-07-17 |
| A Study to Test the Pharmacodynamic, Pharmacokinetic, Safety, and Tolerability of Padsevonil in Healthy Study Participants Receiving Either Ethanol or Cannabidiol (NCT04039919) | UCB Biopharma S.P.R.L. | 2019-07-17 |
| Vancomycin for the Treatment of NAAT(+)/Toxin(-) C. Difficile (NCT03827447) | Medical College of Wisconsin | 2019-07-17 |
| Study of a New Intravenous Drug, Called S65487, in Patients With Acute Myeloid Leukemia, Non Hodgkin Lymphoma, Multiple Myeloma or Chronic Lymphocytic Leukemia (NCT03755154) | Institut de Recherches Internationales Servier | 2019-07-17 |
| A Safety Study of SGN-CD47M in Patients With Solid Tumors (NCT03957096) | Seagen Inc. | 2019-07-17 |
| Comparative Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of Adalimumab in Healthy Subjects (NCT04439929) | Turgut İlaçları A.Ş. | 2019-07-17 |
| A Study in Healthy Men and Women to Test Which Effects Memantine and BI 425809 Have on Each Other (NCT03988803) | Boehringer Ingelheim | 2019-07-17 |
| Efgartigimod Co-administered Subcutaneously With rHuPH20 in Healthy Subjects (NCT04073589) | argenx | 2019-07-17 |
| Combination Camrelizumab (SHR-1210) and Apatinib for Downstaging/Bridging of HCC Before Liver Transplant (NCT04035876) | Zhejiang University | 2019-07-16 |
| Pharmacodynamics and Pharmacokinetics of Aspirin Inhalation Powder With Non-Enteric-Coated Chewable Aspirin (NCT04328883) | Inova Health Care Services | 2019-07-16 |
| A Study to Assess Potential Interaction Between ASP8062 and Alcohol in Healthy Adult Subjects (NCT04003402) | Astellas Pharma Global Development, Inc. | 2019-07-16 |
| A Study of LY3295668 Erbumine in Participants With Extensive-stage Small-Cell Lung Cancer (NCT03898791) | Eli Lilly and Company | 2019-07-16 |
| Safety and Tolerability, Pharmacokinetic and Pharmacodynamic Study With Inzomelid (NCT04015076) | Inflazome UK Ltd | 2019-07-16 |
| AXER-204 in Participants With Chronic Spinal Cord Injury (NCT03989440) | ReNetX Bio, Inc. | 2019-07-16 |
| Relative Exposure and Safety Study of Kimyrsa in ABSSSI Patients (NCT03873987) | Melinta Therapeutics, Inc. | 2019-07-16 |
| Study of TJ004309 in Combination With Atezolizumab (Tecentriq®) in Patients With Advanced or Metastatic Cancer (NCT03835949) | Tracon Pharmaceuticals Inc. | 2019-07-16 |
| Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO (NCT03816345) | National Cancer Institute (NCI) | 2019-07-16 |
| Biodistribution and Kinetics of 18F-AraG in Non-Small Cell Lung Cancer (NCT04052412) | University of Tennessee | 2019-07-16 |
| Phase I Study of BEBT-209 in Women With Advanced Breast Cancer (NCT06047184) | BeBetter Med Inc | 2019-07-15 |
| A Research Study to Compare Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or Obesity (NCT04012255) | Novo Nordisk A/S | 2019-07-15 |
| Bioavailability Study of PF-06651600 Formulations in Healthy Participants (NCT04004663) | Pfizer | 2019-07-15 |
| Study of Proton Therapy in Adjuvant Pancreatic Cancer (NCT03885284) | Georgetown University | 2019-07-15 |
| A Study to Evaluate the Safety, Tolerability, PK, PD, and Clinical Activity of EQ001 in Subjects With aGVHD (NCT03763318) | Biocon Limited | 2019-07-15 |
| Comparation of Chidamide Plus VRD (Bortezomib, Lenalidomide, Dexamethasone) With VRD Regimen for Primary High-Risk Multiple Myeloma Patients (NCT04025450) | The First Affiliated Hospital of Soochow University | 2019-07-15 |
| Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS (NCT04018599) | Fresenius Kabi SwissBioSim GmbH | 2019-07-15 |
| INCMGA00012 Plus Chemotherapy in Participants With Advanced Solid Tumors (POD1UM-105) (NCT03920839) | Incyte Corporation | 2019-07-15 |
| Microbiota Intervention to Change the Response of Parkinson's Disease (NCT03575195) | University of California, San Francisco | 2019-07-15 |
| Safety of SNK01 in Subjects With Pathologically Confirmed Metastatic and/or Unresectable Cancer Refractory to Conventional Therapy (NCT03941262) | NKGen Biotech, Inc. | 2019-07-15 |
| Evaluation of Safety and Tolerability of BI 894416 in Patients With Mild Asthma (NCT03971539) | Boehringer Ingelheim | 2019-07-15 |
| A Study of HX008 for the Treatment of Patients With Metastatic Triple Negative Breast Cancer (NCT04750382) | Taizhou Hanzhong biomedical co. LTD | 2019-07-15 |
| Nivolumab in Combination With Temozolomide and Radiotherapy in Children and Adolescents With Newly Diagnosed High-grade Glioma (NCT04267146) | Gustave Roussy, Cancer Campus, Grand Paris | 2019-07-15 |
| Inhaled Nitric Oxide for Pulmonary Hypertension and Bronchopulmonary Dysplasia (NCT03576885) | AdventHealth | 2019-07-15 |
| Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer (NCT04270591) | Haihe Biopharma Co., Ltd. | 2019-07-15 |
| A Study to Evaluate the Effect of AG-881 on the Pharmacokinetics of a Single Dose of Lamotrigine in Healthy Adults (NCT04015687) | Agios Pharmaceuticals, Inc. | 2019-07-15 |
| Study of Niraparib With Radiotherapy for Treatment of Metastatic Invasive Carcinoma of the Cervix (NCT03644342) | Michelle S Ludwig | 2019-07-15 |
| Bioequivalence Bewteen DopaSnap® (Cabidopa/Levopdoap 25/100 mg Tablet) and Carbidopa/Levodopa 25/100 mg Tablet (Actavis) (NCT04236921) | Riverside Pharmacueticals Corporation | 2019-07-15 |
| ASTX727 in Recurrent/Progressive Non-enhancing IDH Mutant Gliomas (NCT03922555) | Massachusetts General Hospital | 2019-07-12 |
| Improving SCI Rehabilitation Interventions by Retraining the Brain (NCT03892746) | The Cleveland Clinic | 2019-07-12 |
| PRINCE (PSMA-lutetium Radionuclide Therapy and ImmuNotherapy in Prostate CancEr) (NCT03658447) | Peter MacCallum Cancer Centre, Australia | 2019-07-12 |
| A Study of New Transdermal Contraceptive Patch at End of Shelf Life and Currently Marketed EVRA at the Beginning of Shelf Life in Healthy Women (NCT04017195) | Janssen Research & Development, LLC | 2019-07-12 |
| Improving Tissue Oxygenation in Breast Reconstruction Surgery (NCT04020172) | Dr. Glenio Mizubuti (MD, PhD) | 2019-07-12 |
| Study to Compare the Safety and Pharmacokinetics of PK101 With Coadministration of the Two Separate Drugs (NCT03876210) | PMG Pharm Co., Ltd | 2019-07-12 |
| A Personalized Behavioral Intervention to Improve Physical Activity, Sleep and Cognition in Sedentary Older Adults (NCT03959202) | Johns Hopkins University | 2019-07-11 |
| Phase I Study of UCART123 in Patient With Adverse Genetic Risk Acute Myeloid Leukemia (NCT04106076) | Cellectis S.A. | 2019-07-11 |
| The Bioequivalence Study of Two Different Formulations of Candesartan Cilexetil After a Single Oral Dose Administration Under Fasting Conditions (NCT04012307) | Pharmtechnology LLC | 2019-07-11 |
| A Study on Safety and Preliminary Efficacy of ALA in Acne Vulgaris (NCT04018885) | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 2019-07-11 |
| Human IL-15 (rhIL-15) and Obinutuzumab for Relapsed and Refractory Chronic Lymphocyte Leukemia (NCT03759184) | National Cancer Institute (NCI) | 2019-07-11 |
| Study of ASTX295 in Patients With Solid Tumors With Wild-Type p53 (NCT03975387) | Taiho Oncology, Inc. | 2019-07-11 |
| A Clinical Study of Gimatecan in Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer (NCT04029909) | Lee's Pharmaceutical Limited | 2019-07-11 |
| Liposomal Irinotecan Plus 5-FU / LV Combined With Paricalcitol in Patients With Advanced Pancreatic Cancer Progressed on Gemcitabine-based Therapy (NCT03883919) | Washington University School of Medicine | 2019-07-11 |
| A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor (NCT04008797) | Eisai Inc. | 2019-07-11 |
| A Phase I Study of Niraparib Administered Concurrently With Postoperative RT in Triple Negative Breast Cancer Patients (NCT03945721) | Massachusetts General Hospital | 2019-07-11 |
| A Research Study Investigating NNC0247-0829 for Weight Management in People With Overweight or Obesity (NCT04010786) | Novo Nordisk A/S | 2019-07-11 |
| Chiauranib in Combination With Chidamide in Patients With Relapsed/Refractory Non-Hodgkin's Lymphoma (NCT03974243) | Chipscreen Biosciences, Ltd. | 2019-07-11 |
| CD4-specific CAR T Cells (CD4 CAR T Cells) for Relapsed/Refractory T Cell Malignancies (NCT04162340) | iCell Gene Therapeutics | 2019-07-11 |
| A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancer (NCT04019327) | Memorial Sloan Kettering Cancer Center | 2019-07-11 |
| A Phase 1 Trial of CD25/Treg-depleted DLI Plus Ipilimumab for Myeloid Disease Relapse After Matched-HCT (NCT03912064) | Dana-Farber Cancer Institute | 2019-07-10 |
| Study to Investigate Safety, Absorption, Elimination, and Drug Effect of BAY2327949 in Participants With Different Renal Function Status (NCT04004195) | Bayer | 2019-07-10 |
| Ipilimumab, Nivolumab, and Talimogene Laherparepvec Before Surgery in Treating Participants With Localized, Triple-Negative or Estrogen Receptor Positive, HER2 Negative Breast Cancer-deleted (NCT04185311) | Jonsson Comprehensive Cancer Center | 2019-07-10 |
| Griffithsin-based Rectal Microbicide for PREvention of Viral ENTry (PREVENT) (NCT04032717) | Rhonda Brand | 2019-07-10 |
| Porfimer Sodium Interstitial Photodynamic Therapy With or Without Standard of Care Chemotherapy in Treating Patients With Locally Advanced or Recurrent Head and Neck Cancer (NCT03727061) | Roswell Park Cancer Institute | 2019-07-10 |
| 211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome (NCT03670966) | Fred Hutchinson Cancer Center | 2019-07-10 |
| Dual Vaccine Trial in Myeloproliferative Neoplasms (NCT04051307) | Inge Marie Svane | 2019-07-10 |
| Combination HTNV and PUUV DNA Vaccine (NCT03718130) | U.S. Army Medical Research and Development Command | 2019-07-10 |
| Copanlisib and Nivolumab in Treating Patients With Richter's Transformation or Transformed Indolent Non-Hodgkin Lymphoma (NCT03884998) | City of Hope Medical Center | 2019-07-10 |
| A Study of Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems (NCT03814005) | Takeda | 2019-07-10 |
| 177Lu-PSMA-617 Therapy and Olaparib in Patients With Metastatic Castration Resistant Prostate Cancer (NCT03874884) | Peter MacCallum Cancer Centre, Australia | 2019-07-09 |
| A Trial to Evaluate the Pharmacokinetics and Safety of AVYCAZ(R) in Combination With Aztreonam (NCT03978091) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-07-09 |
| Optimizing PTCy Dose and Timing (NCT03983850) | National Cancer Institute (NCI) | 2019-07-09 |
| A First-in-Human Study of the RaniPill, an Oral Drug Delivery Platform (NCT03798912) | RANI Therapeutics | 2019-07-09 |
| Remote Ischemic Conditioning for Intracerebral Hemorrhage (NCT03930940) | Capital Medical University | 2019-07-09 |
| Assessing an Oral EGFR Inhibitor, Sunvozertinib in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR or HER2 Mutation (WU-KONG1) (NCT03974022) | Dizal Pharmaceuticals | 2019-07-09 |
| A Study in Healthy Volunteers (NCT03596697) | Hepion Pharmaceuticals, Inc. | 2019-07-09 |
| A Study to Test the Safety and Tolerability of Single and Multiple Doses of Padsevonil in Adult and Elderly Study Participants (NCT04013191) | UCB Biopharma S.P.R.L. | 2019-07-09 |
| Study of H2 Antagonist and a Proton Pump Inhibitor of Selpercatinib in Healthy Participants (NCT05338502) | Eli Lilly and Company | 2019-07-08 |
| Evaluating the Safety and Immunogenicity of AGS-v PLUS, a Universal Mosquito-Borne Disease and Mosquito Control Vaccine (NCT04009824) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-07-08 |
| CB-839 HCl in Combination With Carfilzomib and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma (NCT03798678) | National Cancer Institute (NCI) | 2019-07-08 |
| Phase 1 Pharmacokinetics, Safety, and Tolerability Study (NCT04067947) | Xgene Pharmaceutical Group | 2019-07-08 |
| Singe Dose Study of PF- 06946860 in Healthy Adult Japanese Participants (NCT03974776) | Pfizer | 2019-07-08 |
| A Fabry Disease Gene Therapy Study (NCT04040049) | Spur Therapeutics | 2019-07-08 |
| ATL001 in Patients With Advanced Unresectable or Metastatic NSCLC (NCT04032847) | Achilles Therapeutics UK Limited | 2019-07-08 |
| CCL21-Gene Modified Dendritic Cell Vaccine and Pembrolizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer (NCT03546361) | Jonsson Comprehensive Cancer Center | 2019-07-08 |
| Study to Evaluate the Mass Balance and Biotransformation of [14C]-Fluzoparib in Chinese Patients With Solid Tumor (NCT04013048) | Jiangsu HengRui Medicine Co., Ltd. | 2019-07-08 |
| Stem Cell Gene Therapy for Cystinosis (NCT03897361) | University of California, San Diego | 2019-07-08 |
| Safety and Efficacy of a Topical Scalp Treatment for Dry Scalp Conditions in Children and Adult (NCT03830177) | Ann & Robert H Lurie Children's Hospital of Chicago | 2019-07-08 |